Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AQST | NFGC |
|---|---|---|
| Price | $4.62 | $1.51 |
| Change today | ▲ 0.22% | ▼ 5.63% |
| Market cap | $579.86M | $580.38M |
| Return, 3 months | +9.0% | -0.7% |
| Return, year to date | -28.5% | -49.2% |
| Return, 1 year | -25.5% | -41.9% |
| P/E (TTM) | -7.0 | -9.8 |
| P/B | -10.2 | 1.6 |
| P/E percentile vs own 5y | 32nd | 67th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +38.1% | – |
| Net profit growth (YoY) | -68.8% | -4.9% |
| Gross margin | 67.0% | 11.1% |
| Operating margin | -97.5% | -232.9% |
| Net margin | -144.6% | -185.4% |
| Return on equity | – | -19.4% |
| Analyst target vs. price | +87.7% | +231.1% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 47 | 36 |
| 30-day volatility | 44.5% | 58.4% |
| Max drawdown, 1 year | -60.6% | -60.9% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
